GO:0071233 cellular response to L-leucine: Nutrient Sensing Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071233 (cellular response to L-leucine) describes any change in a cell's state or activity caused by an L-leucine stimulus, including changes in gene expression, secretion, enzyme production and movement.
• L-leucine is a branched-chain amino acid that acts as a nutrient signal, and its cellular response is closely tied to mTORC1 signaling and mitochondrial adaptation.
• The cytosolic leucine metabolism enzyme BCAT1 modulates the cellular response to leucine and can regulate Th17 cell responses through the mTORC1-HIF1α pathway.
• Leucine availability influences mitochondrial respiration by inhibiting the degradation of outer mitochondrial membrane proteins.
• Dysregulated cellular responses to L-leucine are relevant to cancer progression, diabetes, immune cell function and amino acid stress responses.
• CRISPR knockout, point mutation, knock-in and overexpression models are key tools for dissecting the causal roles of genes involved in the cellular response to L-leucine.
Description
The Gene Ontology term GO:0071233, cellular response to L-leucine, defines any process that results in a change in state or activity of a cell as a result of an L-leucine stimulus. This includes changes in movement, secretion, enzyme production and gene expression. L-leucine is a branched-chain amino acid that functions not only as a building block for protein synthesis but also as a signaling molecule that cells sense and respond to. The cellular response to L-leucine is therefore a central node connecting nutrient availability to cell growth, metabolism and survival. Researchers study this term because it helps formalize how a single amino acid can trigger diverse intracellular programs, from mTORC1 activation to mitochondrial remodeling. The response is also relevant to immune cell fate, as inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway. In disease contexts, altered cellular responses to L-leucine have been linked to cancer progression, diabetes and amino acid stress. Understanding GO:0071233 provides a framework for interpreting how cells integrate leucine signals into physiological and pathological outcomes.
cellular response to L-leucine At A Glance
| GO ID | GO:0071233 |
|---|---|
| GO term | cellular response to L-leucine |
| Ontology | biological_process |
| Synonym | cellular response to leucine |
| Definition | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-leucine stimulus. |
| Major function | Nutrient sensing and signal transduction in response to L-leucine |
| Related pathways | mTORC1 signaling, mitochondrial respiration, amino acid stress responses |
| Key regulators | RNF167, STAMBPL1, BCAT1, mTOR |
| Disease relevance | Cancer, diabetes, immune regulation, amino acid stress |
What Is GO:0071233?
In our own words, GO:0071233 describes the collection of cellular processes triggered when a cell encounters L-leucine. It is not limited to one pathway; rather, it covers any measurable change in cellular state or activity that occurs because of an L-leucine stimulus. This can include altered gene expression, changes in secretion, modified enzyme production, or shifts in cell movement. The term is a biological process and is synonymous with cellular response to leucine. It sits within the broader context of amino acid sensing and nutrient signaling, where L-leucine acts as both a metabolite and a signal.
Why Is cellular response to L-leucine Important in Cell Biology?
GO:0071233 is important because L-leucine is a potent nutrient signal that coordinates cell growth, metabolism and survival. The cellular response to L-leucine intersects with mTORC1 signaling, mitochondrial function and immune cell differentiation, making it a focal point for understanding how cells adapt to nutrient availability. Dysregulation of this response contributes to cancer progression, metabolic disorders and altered immune responses, and it is also relevant to amino acid stress outcomes.
• L-leucine sensing is directly linked to mTORC1, a master regulator of cell growth and proliferation.
• The E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression, connecting leucine responses to tumor biology.
• Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration, linking nutrient signals to mitochondrial quality control.
• BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway, tying leucine to immune cell function.
• Decreased pancreatic islet response to L-leucine is observed in spontaneously diabetic GK rats, linking this process to diabetes.
• Differential cell survival outcomes in response to diverse amino acid stress highlight the importance of leucine-specific responses.
• Cav3.1 has been identified as a neuronal leucine sensor mediating satiety and weight loss in response to dietary protein.
• Protein supplementation can affect satellite cell properties, indicating that leucine responses influence muscle biology.
• Understanding GO:0071233 supports the development of therapeutic strategies targeting nutrient-sensing pathways in cancer and metabolic disease.
What Happens During cellular response to L-leucine?
L-leucine sensing and signal initiation
In simple terms: The cell first detects that L-leucine is present, which triggers a signaling cascade.
The cellular response to L-leucine begins with sensing of the amino acid. L-leucine acts as a nutrient signal that can be detected by cellular machinery, leading to changes in state or activity. This sensing is linked to pathways such as mTORC1 signaling, where L-leucine availability influences downstream effectors. The E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR, indicating that ubiquitin-dependent mechanisms participate in the response to leucine. In neurons, Cav3.1 has been identified as a leucine sensor that mediates satiety and weight loss in response to dietary protein, showing that sensing can occur in specialized cell types.
mTORC1 pathway activation and metabolic reprogramming
In simple terms: Once sensed, L-leucine helps switch on mTORC1, which tells the cell to grow and make proteins.
A central outcome of the cellular response to L-leucine is the modulation of mTORC1 signaling. RNF167 and STAMBPL1 regulate mTOR, and this regulation impacts cancer progression. In immune cells, inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway, demonstrating that leucine metabolism feeds into mTORC1-dependent transcriptional programs. These events lead to changes in gene expression, enzyme production and other cellular activities that define GO:0071233.
Mitochondrial adaptation and respiration
In simple terms: L-leucine also helps mitochondria adjust their energy production by protecting certain mitochondrial proteins.
The cellular response to L-leucine includes mitochondrial adaptation. Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration. This indicates that L-leucine availability can directly influence mitochondrial protein stability and respiratory function. This adaptation is part of the broader cellular response to L-leucine and connects nutrient status to mitochondrial quality control.
Amino acid stress and cell survival decisions
In simple terms: When amino acids like leucine are scarce or imbalanced, cells decide whether to survive or die.
The cellular response to L-leucine is also relevant in the context of amino acid stress. Differential cell survival outcomes are observed in response to diverse amino acid stress, including leucine-related stress. This suggests that the cellular response to L-leucine can influence cell fate decisions under stress conditions. The integration of leucine signals with stress pathways determines whether cells adapt or undergo death, which is important for understanding diseases such as cancer and metabolic disorders.
Immune cell regulation and Th17 responses
In simple terms: In immune cells, leucine metabolism helps control inflammation by affecting Th17 cells.
The cellular response to L-leucine extends to immune regulation. Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway. This demonstrates that leucine metabolism within immune cells can shape inflammatory responses. The cellular response to L-leucine therefore includes changes in immune cell activity and gene expression, consistent with the GO definition.
Key Genes Involved in GO:0071233 cellular response to L-leucine
The following genes and proteins are experimentally implicated in the cellular response to L-leucine, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNF167 | E3 ligase that modulates mTOR | Regulates mTOR and cancer progression in response to leucine |
| STAMBPL1 | Deubiquitinase that modulates mTOR | Regulates mTOR and cancer progression in response to leucine |
| MTOR | Central kinase in nutrient sensing | Key effector of leucine signaling and mTORC1 pathway |
| BCAT1 | Cytosolic leucine metabolism enzyme | Regulates Th17 responses via mTORC1-HIF1α |
| HIF1A | Transcription factor downstream of mTORC1 | Mediates Th17 responses in leucine metabolism |
| CACNA1G | Cav3.1 calcium channel | Neuronal leucine sensor mediating satiety and weight loss |
| SLC7A5 | Amino acid transporter | Involved in leucine uptake and mTORC1 activation (implied by nutrient sensing context) |
| SLC3A2 | Amino acid transporter subunit | Part of the leucine transport machinery (implied by nutrient sensing context) |
| LARS1 | Leucyl-tRNA synthetase | Potential leucine sensor (implied by amino acid sensing context) |
| SESN2 | Sestrin 2 | Potential mediator of amino acid stress responses |
| DDIT3 | CHOP, stress-induced transcription factor | Involved in amino acid stress and cell survival |
| EIF2AK3 | PERK, ER stress kinase | Linked to amino acid stress responses |
| ATF4 | Stress-responsive transcription factor | Mediates amino acid stress gene expression |
| RPTOR | mTORC1 component | Part of mTORC1 complex regulated by leucine |
| MLST8 | mTORC1 component | Part of mTORC1 complex regulated by leucine |
| DEPTOR | mTORC1 inhibitor | Modulates mTORC1 activity in response to nutrients |
| AKT1 | Upstream kinase | Crosstalk with mTORC1 in leucine response |
How Is cellular response to L-leucine Regulated?
The cellular response to L-leucine is regulated at multiple levels. The mTORC1 pathway is a central node, with RNF167 and STAMBPL1 modulating mTOR activity and cancer progression. BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway, showing that metabolic enzymes can control the response. Mitochondrial adaptation through inhibition of outer mitochondrial membrane protein degradation provides another layer of regulation. Additionally, amino acid stress pathways influence cell survival decisions, indicating that the response is integrated with stress signaling. Neuronal leucine sensing by Cav3.1 mediates satiety and weight loss, demonstrating specialized regulatory mechanisms in different cell types.
cellular response to L-leucine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNF167 | Cancer progression via mTOR modulation | Knockout and overexpression in cancer cell lines |
| STAMBPL1 | Cancer progression via mTOR modulation | Knockout and overexpression in cancer cell lines |
| BCAT1 | Th17-mediated inflammation | Knockout in T cell differentiation models |
| CACNA1G | Satiety and weight loss | Knockout in neuronal cell models |
| MTOR | Cancer and metabolic disorders | Point mutation and knock-in models |
Cancer progression and mTOR signaling
The cellular response to L-leucine is linked to cancer through the E3 ligase RNF167 and deubiquitinase STAMBPL1, which modulate mTOR and cancer progression. Dysregulated mTOR signaling downstream of leucine sensing can promote tumor growth. Targeting components of this response may offer therapeutic opportunities in cancers dependent on nutrient sensing.
Diabetes and pancreatic islet dysfunction
Decreased pancreatic islet response to L-leucine has been observed in spontaneously diabetic GK rats, with enzymatic, metabolic and secretory data supporting this defect. This links the cellular response to L-leucine to diabetes pathogenesis. Understanding how islet cells respond to L-leucine may inform strategies for preserving beta-cell function.
Immune regulation and Th17-mediated inflammation
Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway. This connects the cellular response to L-leucine with autoimmune and inflammatory conditions driven by Th17 cells. Modulating leucine metabolism could therefore influence immune-mediated diseases.
Amino acid stress and cell survival
Differential cell survival outcomes in response to diverse amino acid stress highlight the importance of leucine-specific stress responses. Cells must integrate leucine availability with stress pathways to decide between survival and death. This has implications for diseases where amino acid stress contributes to pathology.
From cellular response to L-leucine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RNF167 regulate mTOR in response to L-leucine? | RNF167 knockout cell line |
| Does STAMBPL1 modulate cancer progression via leucine sensing? | STAMBPL1 overexpression and knockout |
| How does BCAT1 control Th17 responses? | BCAT1 knockout in T cells |
| Is Cav3.1 required for leucine sensing in neurons? | CACNA1G knockout neuronal cells |
| What is the role of mitochondrial protein degradation in leucine response? | Tagged knock-in of outer mitochondrial membrane proteins |
| How do cells survive amino acid stress? | Point mutation in stress pathway genes |
How to Study the cellular response to L-leucine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in gene expression | Identifying transcriptional responses to L-leucine |
| Ribo-seq | Changes in translation | Measuring mTORC1-dependent translation |
| Phosphoproteomics | Changes in protein phosphorylation | Detecting mTORC1 substrate phosphorylation |
| Metabolic flux analysis | Leucine metabolism and utilization | Studying BCAT1-mediated leucine metabolism |
| Calcium imaging | Neuronal activity and sensing | Studying Cav3.1 as a leucine sensor |
| Cell survival assays | Apoptosis and viability | Assessing amino acid stress outcomes |
| Western blot | Protein expression and degradation | Measuring outer mitochondrial membrane protein stability |
| CRISPR screening | Gene function at scale | Identifying regulators of leucine response |
Transcriptomic and translatomic profiling
RNA-seq and Ribo-seq can measure changes in gene expression and translation following L-leucine stimulation. These methods help identify genes and pathways that define the cellular response to L-leucine, including mTORC1 targets.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation after L-leucine treatment. This is useful for studying mTORC1 substrates and mitochondrial protein stability.
Metabolic and flux assays
Metabolic assays can measure leucine metabolism and its impact on cellular energetics. BCAT1-mediated cytosolic leucine metabolism can be assessed using isotope tracing and enzyme activity assays.
Imaging and sensor-based approaches
Fluorescent sensors and imaging can visualize leucine sensing and downstream signaling in live cells. Neuronal leucine sensing by Cav3.1 can be studied using calcium imaging and electrophysiology.
How CRISPR Can Be Used to Study GO:0071233 cellular response to L-leucine
Knockout
CRISPR knockout is used to delete genes such as RNF167, STAMBPL1, BCAT1 or CACNA1G to test their requirement in the cellular response to L-leucine. For example, RNF167 knockout can reveal its role in mTOR modulation and cancer progression. BCAT1 knockout in T cells can show its impact on Th17 responses.
Point Mutation
Point mutations can be introduced to dissect specific residues required for leucine sensing or signaling. For instance, mutating phosphorylation sites in mTORC1 components can clarify their regulation by L-leucine. Point mutations in BCAT1 can separate its enzymatic activity from its role in Th17 regulation.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of proteins involved in the leucine response. Tagged knock-in of outer mitochondrial membrane proteins can monitor their degradation upon leucine stimulation. Knock-in of fluorescent reporters for mTORC1 activity can visualize signaling dynamics.
Overexpression
Overexpression of genes such as RNF167, STAMBPL1 or BCAT1 can test sufficiency in driving leucine-related phenotypes. Overexpression of STAMBPL1 may enhance mTOR signaling and cancer progression. Overexpression of BCAT1 can modulate Th17 differentiation through the mTORC1-HIF1α pathway.
How EDITGENE Supports cellular response to L-leucine Research
Researchers studying cellular response to L-leucine-related genes often need to determine whether a candidate gene is causally involved in sensing, signaling or metabolic adaptation. EDITGENE provides CRISPR-based cell model services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for cellular response to L-leucine research.
Frequently Asked Questions About cellular response to L-leucine
What is GO:0071233 cellular response to L-leucine?
GO:0071233 is a Gene Ontology biological process term describing any change in a cell's state or activity as a result of an L-leucine stimulus, including changes in gene expression, secretion, enzyme production and movement.
What genes are involved in the cellular response to L-leucine?
Genes such as RNF167, STAMBPL1, MTOR, BCAT1, HIF1A and CACNA1G have been implicated in the cellular response to L-leucine.
How does L-leucine activate mTORC1?
L-leucine sensing leads to modulation of mTORC1 signaling, with regulators such as RNF167 and STAMBPL1 influencing mTOR activity.
What is the role of BCAT1 in leucine response?
BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway.
Is the cellular response to L-leucine relevant to cancer?
Yes, RNF167 and STAMBPL1 modulate mTOR and cancer progression, linking leucine responses to tumor biology.
How is the cellular response to L-leucine studied?
Researchers use RNA-seq, Ribo-seq, proteomics, metabolic assays and imaging to study the response, often combined with CRISPR knockout or overexpression models.
What is the connection between L-leucine and mitochondrial respiration?
Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration.
Does L-leucine affect immune cells?
Yes, inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway.
What diseases are linked to altered cellular response to L-leucine?
Cancer, diabetes and immune-mediated inflammation have been linked to altered leucine responses.
Can CRISPR be used to study the cellular response to L-leucine?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are used to dissect gene function in this process.
Conclusion
GO:0071233 cellular response to L-leucine captures a critical interface between nutrient sensing and cell fate. The process involves mTORC1 signaling, mitochondrial adaptation, immune regulation and stress responses, with key roles for genes such as RNF167, STAMBPL1, BCAT1 and CACNA1G. Dysregulation of this response contributes to cancer, diabetes and inflammatory diseases, making it a valuable target for research. CRISPR-based models and multi-omics methods provide powerful tools to dissect the mechanisms and therapeutic potential of the cellular response to L-leucine.
References
- 1. Wang D et al.. 2022. E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.. Mol Cell 82(4):770-784.e9 PMID: 35114100
- 2. Li Q et al.. 2025. Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration.. Nat Cell Biol 27(11):1889-1901 PMID: 41174002
- 3. Kang YJ et al.. 2024. Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway.. Exp Mol Med 56(8):1776-1790 PMID: 39085353
- 5. Giroix MH et al.. 1999. Decreased pancreatic islet response to L-leucine in the spontaneously diabetic GK rat: enzymatic, metabolic and secretory data.. Diabetologia 42(8):965-77 PMID: 10491757
- 6. Russier M et al.. 2025. Differential cell survival outcomes in response to diverse amino acid stress.. Life Sci Alliance 8(11) PMID: 40912912
- 7. Tsang AH et al.. 2026. Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein.. Cell Metab 38(5):876-890.e13 PMID: 42025169
